| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/07/2006 | US20060199958 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199855 Process for producing atorvastatin hemicalcium |
| 09/07/2006 | US20060199854 allows to recycle all solvents and the only by-products are inorganic salts; high overall yield and is suitable for industrial production |
| 09/07/2006 | US20060199848 Ion channel modulating activity II |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199772 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 09/07/2006 | US20060198893 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and excipient like middle chain triglycerides |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1698622A1 Agent or method for treatment for severe aphasia in chronic-stage cerebrovascular disorder |
| 09/06/2006 | EP1698621A1 Method for producing pyrrolidine derivative |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 09/06/2006 | EP1697329A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 09/06/2006 | EP1697319A1 Pyrrole compounds |
| 09/06/2006 | EP1697318A1 Prolinylarylacetamides |
| 09/06/2006 | EP1696919A2 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 09/06/2006 | EP1546096B1 Process for the preparation of amino-pyrrolidine derivatives |
| 09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 09/06/2006 | EP1438042B1 Polymaleimide compounds and their medical use |
| 09/06/2006 | EP1274423A4 Medicine for treating traumatic brain injury and other neuronal disorders |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829688A Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 09/06/2006 | CN1827597A Process for preparing 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester |
| 09/06/2006 | CN1273449C Crystalline forms of atorvastatin |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102024 Functional biopolymer modification reagents and uses thereof |
| 09/05/2006 | US7102015 Maleimide compounds in liquid form |
| 09/05/2006 | US7101980 Derivatives, conjugates, and antibodies for detecting ecstasy-class analytes |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2006 | US7101897 Farnesyl transferase inhibitors |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101894 Administering quinoline derivative for therapy of Cytomegalovirus infections in human pathogen |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101885 1-(4-Bromo-phenyl)-3-[2-(4-methyl-piperazin-1-yl)-pyridin-3-yloxy]-pyrrolidin-2-one; antagonists of the serotonin 5HT1B receptor; treating depression |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/01/2006 | CA2499047A1 Process for producing atorvastatin hemicalcium |
| 08/31/2006 | WO2006090920A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR δ |
| 08/31/2006 | WO2006090265A2 Processes for the preparation of levetiracetam, its intermediate and the use of levetiracetam in pharmaceutical compositions |
| 08/31/2006 | WO2006090244A1 New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them |
| 08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | WO2006090192A1 Medicaments for alzheimer |
| 08/31/2006 | WO2006089909A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | WO2006089401A1 An improved process for the preparation of atorvastatin and intermediates |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006066839A3 Method for producing pyrrolidones from succinates from fermentation broths |
| 08/31/2006 | US20060194867 Process for the preparation of atorvastatin and intermediates |
| 08/31/2006 | US20060194865 G-lactam derivatives as prostaglandin agonists |
| 08/31/2006 | US20060194862 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 08/31/2006 | US20060194857 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194781 Alkyl ether derivatives or salts thereof |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | CA2599454A1 Activator for peroxisome proliferator activating receptor d |
| 08/31/2006 | CA2599021A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1695955A1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| 08/30/2006 | EP1694775A1 Reagent for detecting an analyte |
| 08/30/2006 | EP1694722A1 Polyamine salts as clay stabilizing agents |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1368389B1 Complexed compounds and use thereof for the polymerisation of olefins |
| 08/30/2006 | EP1317429B1 Amidine inhibitors of serine proteases |
| 08/30/2006 | EP1020439B1 Cetp activity inhibitors |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826314A Method for production of dollar g(a), dollar g(b)-unsaturated amide compounds |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/30/2006 | CN1824653A Color conversion film and multicolor light-emitting device provided with the same |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272291C Method for the production of a purified melt of at least one monomer |
| 08/30/2006 | CN1272105C Catalysts comprising N-substituted cyclic imides and processes for preparing organic compounds with catalysts |
| 08/30/2006 | CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase |
| 08/29/2006 | CA2521980C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2521958C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-pheyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2239183C Branched hydrazone linkers |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/28/2006 | CA2498978A1 An improved process for the preparation of atorvastatin and intermediates |
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | WO2006088525A1 Synthetic process for aminocyclohexyl ether compounds |
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |